VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Medtronic plc vs Merck & Co., Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Medtronic plc
MDT · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Medtronic plc's moat claims, evidence, and risks.
View MDT analysisMerck & Co., Inc.
MRK · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Merck & Co., Inc.'s moat claims, evidence, and risks.
View MRK analysisComparison highlights
- Moat score gap: Merck & Co., Inc. leads (71 / 100 vs 63 / 100 for Medtronic plc).
- Segment focus: Medtronic plc has 4 segments (37.2% in Cardiovascular Portfolio); Merck & Co., Inc. has 2 segments (89.5% in Pharmaceutical).
- Primary market structure: Oligopoly vs Competitive. Pricing power: Moderate vs Moderate.
- Moat breadth: Medtronic plc has 9 moat types across 3 domains; Merck & Co., Inc. has 5 across 3.
Primary market context
Medtronic plc
Cardiovascular Portfolio
Cardiovascular medical devices (cardiac rhythm management, electrophysiology/ablation, structural heart, coronary & peripheral vascular)
Global
Hospitals, cath labs, electrophysiologists, cardiologists, cardiac & vascular surgeons
Device OEM + procedure support + remote monitoring software/services
37.2%
Merck & Co., Inc.
Pharmaceutical
Branded prescription pharmaceuticals & human vaccines
Global
Wholesalers/retailers, managed care and government payers, hospitals/clinics
R&D-intensive innovator, manufacturer, and marketer
89.5%
Side-by-side metrics
Moat coverage
Shared moat types
Medtronic plc strengths
Merck & Co., Inc. strengths
Segment mix
Medtronic plc segments
Full profile >Cardiovascular Portfolio
Oligopoly
Neuroscience Portfolio
Oligopoly
Medical Surgical Portfolio
Competitive
Diabetes Operating Unit
Oligopoly
Merck & Co., Inc. segments
Full profile >Pharmaceutical
Competitive
Animal Health
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.